Lunate Capital LTD Revolution Medicines, Inc. Transaction History
Lunate Capital LTD
- $178 Billion
- Q2 2025
A detailed history of Lunate Capital LTD transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Lunate Capital LTD holds 2,196,200 shares of RVMD stock, worth $84 Million. This represents 45.37% of its overall portfolio holdings.
Number of Shares
2,196,200
Previous 2,196,200
-0.0%
Holding current value
$84 Million
Previous $77.7 Billion
4.04%
% of portfolio
45.37%
Previous 45.36%
Shares
1 transactions
Others Institutions Holding RVMD
# of Institutions
307Shares Held
189MCall Options Held
186KPut Options Held
672K-
Vanguard Group Inc Valley Forge, PA16.6MShares$636 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA13.5MShares$518 Million2.75% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$513 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA11.8MShares$451 Million0.08% of portfolio
-
Janus Henderson Group PLC London, X010.2MShares$390 Million0.21% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.36B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...